European treatment targets for drug-resistant TB 'failing to be met'
This article was originally published in Scrip
Executive Summary
Tuberculosis (TB) cases have fallen by an average of 5% annually in Europe over the past decade. Worryingly, however, targets set for the treatment of multidrug-resistant TB have not been met, according to new data published by the European Centre for Disease Prevention and Control and the WHO Regional Office for Europe.